Clinical trial
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
NCT00243022 · Ali Altunkaya, Other · Terminated
Key facts
| NCT number | NCT00243022 |
|---|---|
| Title | Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme |
| Official title | Phase II Randomized Evaluation of 5-Lipoxygenase Inhibition by Herbal Complementary and Alternative Medicine Approach Compared to Control as an Adjuvant Therapy in Newly Diagnosed and Recurrent High-grade Gliomas |
| Lead sponsor | Ali Altunkaya, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Cerebral Edema |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Boswellia serrata extract, cyanocobalamin |
| Enrollment | 12 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Oct 21, 2005 |
| Last update posted | Apr 30, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: